Inderal successfully prevented the recurrence of polymorphic ventricular tachycardia in a patient with a normal QT interval who was unresponsive to standard treatments.
Case Report (n=1)
Does propranolol prevent recurrent polymorphic ventricular tachycardia in a patient with a normal QT interval?
Propranolol may be an effective treatment for recurrent polymorphic ventricular tachycardia in patients without QT prolongation when standard therapies fail.
Polymorphic ventricular tachycardia (PVT) is a group of life-threatening heart rhythm disorders. These arrhythmias share similar electrocardiographic characteristics but require different modes of therapy for effective treatment. It is important to note that the medications that are considered the first-line treatment for one type of PVT may not be appropriate for another type, and may worsen the condition. Therefore, it is crucial to accurately diagnose the type of PVT before initiating treatment to provide the most effective therapy for the patient. A 42-year-old man was admitted to the emergency department with dyspnea, Levine sign, and severe chest pain. His electrocardiogram showed ST elevation, and the QT interval was normal. The patient was sent to the cath lab based on the treatment protocols. According to the results of angiography, three coronary arteries were severely obstructed. His coronary arteries did not open during percutaneous coronary intervention; thus, the healthcare team decided on open heart surgery. He suffered from recurrent PVT following open heart surgery and did not respond to any of the drugs suitable for this type of tachycardia. Inderal prevented the recurrence of ventricular tachycardia (VT) in a patient with polymorphic VT without QT prolongation, contrary to the healthcare team's expectations. Inderal was used as the last line of treatment because this patient's arrhythmia was polymorphic VT without QT prolongation. Inderal is typically used for treating VT in patients with long QT syndromes and heart structural disorders. This case report aims to highlight the impact of Inderal on polymorphic tachycardia, specifically in cases where the QT interval is not elongated. In this particular case, the standard treatment approaches were ineffective in preventing reversibility, but Inderal proved to be successful. Therefore, we feel it is important to document and share this case.
Shafiee et al. (Mon,) conducted a case report in Polymorphic ventricular tachycardia with normal QT interval (n=1). Inderal vs. Standard treatment approaches was evaluated on Prevention of recurrence of ventricular tachycardia. Inderal successfully prevented the recurrence of polymorphic ventricular tachycardia in a patient with a normal QT interval who was unresponsive to standard treatments.